New injection slows down early puberty in kids

NCT ID NCT05341115

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a drug called leuprorelin to control central precocious puberty, a condition where children start puberty too early. About 80 children received an injection every 12 weeks for 6 months. The goal was to suppress hormones that drive early puberty, helping children develop at a more normal pace.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL PRECOCIOUS PUBERTY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

central precocious puberty precocious puberty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Children's Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100033, China

  • Provincial Hospital Affiliated to Shandong First Medical University

    Jinan, Shandong, 250021, China

  • Shanghai Children's Hospital

    Shanghai, Shanghai Municipality, 200062, China

  • The Hospital attached by the Torigji Medical College, Huazhong Science and Technology University.

    Wuhan, Hubei, 430030, China

  • the First A liated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510062, China